Glutaminolysis is Essential for Myofibroblast Persistence and In Vivo Targeting Reverses Fibrosis and Cardiac Dysfunction in Heart Failure

dc.contributor.author	Gibb, Andrew A
dc.contributor.author	Murray, Emma K
dc.contributor.author	Huynh, Anh T
dc.contributor.author	Gaspar, Ryan B
dc.contributor.author	Ploesch, Tori L
dc.contributor.author	Bedi, Ken
dc.contributor.author	Lombardi, Alyssa A
dc.contributor.author	Lorkiewicz, Pawel K
dc.contributor.author	Roy, Rajika
dc.contributor.author	Arany, Zolt
dc.contributor.author	Kelly, Daniel P
dc.contributor.author	Margulies, Kenneth B
dc.contributor.author	Hill, Bradford G
dc.contributor.author	Elrod, John W
dc.date.accessioned	2023-09-01T16:07:08Z
dc.date.available	2023-09-01T16:07:08Z
dc.date.issued	2022-05-24
dc.date.updated	2023-09-01T16:07:07Z
dc.identifier.issn	0009-7322
dc.identifier.issn	1524-4539
dc.identifier.uri	https://hdl.handle.net/10161/28924
dc.language	en
dc.publisher	Ovid Technologies (Wolters Kluwer Health)
dc.relation.ispartof	Circulation
dc.relation.isversionof	10.1161/circulationaha.121.057879
dc.title	Glutaminolysis is Essential for Myofibroblast Persistence and In Vivo Targeting Reverses Fibrosis and Cardiac Dysfunction in Heart Failure
dc.type	Journal article
duke.contributor.orcid	Roy, Rajika\|0000-0001-9394-3224
pubs.begin-page	1625
pubs.end-page	1628
pubs.issue	21
pubs.organisational-group	Duke
pubs.organisational-group	School of Medicine
pubs.organisational-group	Clinical Science Departments
pubs.organisational-group	Surgery
pubs.organisational-group	Surgery, Cardiovascular and Thoracic Surgery
pubs.publication-status	Published
pubs.volume	145

Files

Now showing 1 - 1 of 1